Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code B37.1

Pulmonary candidiasis.Infection of the lungs caused by the yeast Candida.

Use additional code to identify resistance to antimicrobial drugs (Z16.-). Do not code pulmonary candidiasis if it is a neonatal infection (P37.5).

Medical necessity for treating pulmonary candidiasis is established by confirming the presence of the infection in the lungs and demonstrating clinical symptoms that require intervention. The severity of the infection, the patient's overall health status, and the potential risks and benefits of treatment should all be considered.

Clinicians diagnose pulmonary candidiasis based on patient history, physical examination, and laboratory tests such as complete blood count (CBC), T2Candida panel, blood culture, bronchoscopy, and polymerase chain reaction (PCR). Treatment involves systemic antifungal medications.

In simple words: Pulmonary candidiasis is a lung infection caused by the yeast Candida.It can happen after surgery or when a Candida infection spreads from another part of your body to your lungs through your blood.

Pulmonary candidiasis is an infection of the lungs caused by the yeast Candida albicans. This can occur as a result of surgery or dissemination (spread) of candida infection through the bloodstream from elsewhere in the body.

Example 1: A patient with a weakened immune system due to chemotherapy develops a persistent cough, shortness of breath, and fever.A chest X-ray reveals fungal infiltrates, and sputum cultures confirm Candida albicans, leading to a diagnosis of pulmonary candidiasis., Following abdominal surgery, a patient develops fever, chills, and difficulty breathing. Blood cultures and bronchoalveolar lavage identify Candida, indicating disseminated candidiasis with lung involvement., An individual with HIV and a low CD4 count presents with a productive cough and chest pain.A bronchoscopy with biopsy reveals pulmonary candidiasis, consistent with their immunocompromised state.

Documentation should include evidence of Candida infection in the lungs, such as positive cultures from sputum or bronchoalveolar lavage, imaging findings consistent with pulmonary candidiasis, and relevant clinical signs and symptoms like cough, fever, and shortness of breath.Underlying conditions that may predispose the patient to candidiasis should also be documented.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.